APA

Büller H. R., Gallus A. S., Pillion G., Prins M. H. & Raskob G. E. (20120207). Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. : Lancet (London, England).

Chicago

Büller Harry R, Gallus Alex S, Pillion Gerard, Prins Martin H and Raskob Gary E. 20120207. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. : Lancet (London, England).

Harvard

Büller H. R., Gallus A. S., Pillion G., Prins M. H. and Raskob G. E. (20120207). Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. : Lancet (London, England).

MLA

Büller Harry R, Gallus Alex S, Pillion Gerard, Prins Martin H and Raskob Gary E. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. : Lancet (London, England). 20120207.